{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T20:09:42Z","timestamp":1794600582981,"version":"4.9.1"},"reference-count":96,"publisher":"Baishideng Publishing Group Inc.","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3748\/wjg.v20.i29.9912","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T00:33:34Z","timestamp":1407717214000},"page":"9912","source":"Crossref","is-referenced-by-count":130,"title":["Antimicrobial susceptibility testing for<i>Helicobacter pylori<\/i>in times of increasing antibiotic resistance"],"prefix":"10.3748","volume":"20","author":[{"given":"Sin\u00e9ad M","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2857"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1001110"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302084"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i45.8168"},{"key":"ref5","unstructured":"Iwa\u0144czak F, Iwa\u0144czak B. Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance. Adv Clin Exp Med 2012;21:671-680."},{"key":"ref6","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Infection with Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:177-240."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut 2001;48:287-289.","DOI":"10.1136\/gut.48.3.287"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02203.x"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1083-4389.2004.00235.x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00668.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0069-z"},{"key":"ref12","unstructured":"Loy CT, Irwig LM, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. Am J Gastroenterol 1996;91:1138-1144."},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Feldman RA, Deeks JJ, Evans SJ. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group. Eur J Clin Microbiol Infect Dis 1995;14:428-433.","DOI":"10.1007\/BF02114899"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101634"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01393.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Jonkers D, Stobberingh E, de Bruine A, Arends JW, Stockbr&uuml;gger R. Evaluation of immunohistochemistry for the detection of Helicobacter pylori in gastric mucosal biopsies. J Infect 1997;35:149-154.","DOI":"10.1016\/S0163-4453(97)91611-X"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00223.x"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of gastritis. Arch Pathol Lab Med 2008;132:1586-1593.","DOI":"10.5858\/2008-132-1586-PATTPD"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05083.x"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280503"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Axon AT, O&rsquo;Mor&aacute;in CA, Bardhan KD, Crowe JP, Beattie AD, Thompson RP, Smith PM, Hollanders FD, Baron JH, Lynch DA. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. BMJ 1997;314:565-568.","DOI":"10.1136\/bmj.314.7080.565"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.034629"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.2.187"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41688.x"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-1888.","DOI":"10.1093\/jnci\/92.23.1881"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.072009"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj264"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41384.x"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, Grilli D, Bazzoli F. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:121-128.","DOI":"10.7326\/0003-4819-151-2-200907210-00009"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004;53:34-37.","DOI":"10.1136\/gut.53.1.34"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577.","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji277"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.3903"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, M&eacute;graud F, O&rsquo;Morain C, Bell D, Bianchi Porro G, Deltenre M, Forman D, Gasbarrini G, Jaup B, Misiewicz JJ. Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997;9:1-2.","DOI":"10.1097\/00042737-199701000-00002"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05982.x"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12075"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X09337342"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.192757"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp003"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq405"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i31.3865"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302254"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2004.09.008"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01500.x"},{"key":"ref45","unstructured":"Health Protection Agency UK. Investigation of gastric biopsies for Helicobacter pylori. Health Protection Agency Standards Unit, Standards and Evaluation laboratory 2012. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hpa.org.uk\/webc\/hpawebfile\/hpaweb_c\/1317132860197\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.hpa.org.uk\/webc\/hpawebfile\/hpaweb_c\/1317132860197<\/ext-link>."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00033-06"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Dent JC, McNulty CA. Evaluation of a new selective medium for Campylobacter pylori. Eur J Clin Microbiol Infect Dis 1988;7:555-558.","DOI":"10.1007\/BF01962615"},{"key":"ref48","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. 2013; Version 3.1. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Consultation\/EUCAST_clinical_breakpoints_for_Helicobacter_pylori.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Consultation\/EUCAST_clinical_breakpoints_for_Helicobacter_pylori.pdf<\/ext-link>."},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Savarino V, Zentilin P, Pivari M, Bisso G, Raffaella Mele M, Bilardi C, Borro P, Dulbecco P, Tessieri L, Mansi C. The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Aliment Pharmacol Ther 2000;14:893-900.","DOI":"10.1046\/j.1365-2036.2000.00780.x"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Pilotto A, Rassu M, Leandro G, Franceschi M, Di Mario F. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer. Dig Liver Dis 2000;32:763-768.","DOI":"10.1016\/S1590-8658(00)80352-7"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.169_b.x"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2007.12.005"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1586\/erm.11.17"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2003.09.015"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp445"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-603"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00744-09"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Gibson JR, Saunders NA, Burke B, Owen RJ. Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. J Clin Microbiol 1999;37:3746-3748.","DOI":"10.1128\/JCM.37.11.3746-3748.1999"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2010.02.021"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.4.1217-1220.2001"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-112"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.12.002"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00103-07"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.10.4512-4518.2004"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2011.00845.x"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Wang LH, Cheng H, Hu FL, Li J. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains. World J Gastroenterol 2010;16:2272-2277.","DOI":"10.3748\/wjg.v16.i18.2272"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00614-06"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.8.3166-3170.2005"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki199"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.08.010"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2010.00788.x"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2011.05.002"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.07.017"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Glupczynski Y, M&eacute;graud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001;20:820-823.","DOI":"10.1007\/s100960100611"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02248.x"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03386.x"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Dore MP, Leandro G, Realdi G, Sepulveda AR, Graham DY. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 2000;45:68-76.","DOI":"10.1023\/A:1005457226341"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr293"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60020-2"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Bardhan K, Bayerd&ouml;rffer E, Veldhuyzen Van Zanten SJ, Lind T, M&eacute;graud F, Delchier JC, Hellblom M, Stubber&ouml;d A, Burman CF, Gromark P. The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection. Helicobacter 2000;5:196-201.","DOI":"10.1046\/j.1523-5378.2000.00030.x"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328338e43d"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-013-0957-3"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12046"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06815.x"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12031"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Wenzhen Y, Yumin L, Quanlin G, Kehu Y, Lei J, Donghai W, Lijuan Y. Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials. Intern Med 2010;49:1103-1109.","DOI":"10.2169\/internalmedicine.49.3031"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Romano M, Marmo R, Cuomo A, De Simone T, Mucherino C, Iovene MR, Montella F, Tufano MA, Del Vecchio Blanco C, Nardone G. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. Clin Gastroenterol Hepatol 2003;1:273-278.","DOI":"10.1016\/S1542-3565(03)00131-9"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Qasim A, Sebastian S, Buckley M, O&rsquo;Connor H, O&rsquo;Morain C. Pretreatment antimicrobial susceptibility testing is not cost saving in the standard eradication of Helicobacter pylori. Clin Gastroenterol Hepatol 2004;2:85; discussion 85.","DOI":"10.1016\/S1542-3565(03)00296-9"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Faber J, Bar-Meir M, Rudensky B, Schlesinger Y, Rachman E, Benenson S, Sirota G, Stankiewic H, Halle D, Wilschanski M. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful? J Pediatr Gastroenterol Nutr 2005;40:571-574.","DOI":"10.1097\/01.MPG.0000155567.71902.75"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03844.x"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.007"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks407"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992;11:777-781.","DOI":"10.1007\/BF01960875"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01067-11"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-011-1170-6"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-12-3"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i29\/9912.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T03:14:47Z","timestamp":1649906087000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v20\/i29\/9912.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":96,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v20.i29.9912","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}